lipopeptides - CISMeF

Preferred Label : lipopeptides;

MeSH definition : Compounds consisting of a short peptide chain conjugated with an acyl chain.;

MeSH synonym : Lipopeptide;

MeSH hyponym : anionic lipopeptides; cationic lipopeptides; Lipopeptides, Anionic; Anionic Lipopeptide; Lipopeptide, Anionic; Lipopeptides, Cationic; Cationic Lipopeptide; Lipopeptide, Cationic;

Is substance : O;

Details

Origin ID

D055666;

UMLS CUI

C2266975;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- FP6 protein, arabidopsis [MeSH Supplementary Concept]
- NHBA protein, Neisseria meningitidis [MeSH Supplementary Concept]
- circulocin delta [MeSH Supplementary Concept]
- circulocin gamma [MeSH Supplementary Concept]
- cyclic lipopeptide 4 [MeSH Supplementary Concept]
- palmitoyl-PrRP31 peptide, human [MeSH Supplementary Concept]
- stearyl-(D)-K6L9 peptide [MeSH Supplementary Concept]
Record concept(s)
- anionic lipopeptides [MeSH concept]
- cationic lipopeptides [MeSH concept]
- lipopeptides [MeSH concept]
Related MeSH Supplementary Concept(s)
- (Val8)GLP-1-Glu-PAL [MeSH Supplementary Concept]
- 1-(N-acetyl-ALYDKGYTSKEQKDCVGI)-2-arachidonoyl-3-stearoyl glyceride [MeSH Supplementary Concept]
- 2,3-bis(palmitoyloxy)-2-propyl-N-palmitoyl-cysteinyl-seryl-seryl-asparaginyl-alanine [MeSH Supplementary Concept]
- ATI-2341 [MeSH Supplementary Concept]
- Antimicrobial Peptide PE2 [MeSH Supplementary Concept]
- Bk-1119 [MeSH Supplementary Concept]
- Bk-1213 [MeSH Supplementary Concept]
- Bk-1215 [MeSH Supplementary Concept]
- C17 fengycin A [MeSH Supplementary Concept]
- CB-183,315 [MeSH Supplementary Concept]
- EG00086 [MeSH Supplementary Concept]
- F2Pal-10 pepducin [MeSH Supplementary Concept]
- F2pal-12 pepducin [MeSH Supplementary Concept]
- F2pal-16 pepducin [MeSH Supplementary Concept]
- FR 209602 [MeSH Supplementary Concept]
- FR 901469 [MeSH Supplementary Concept]
- FW523-3 compound [MeSH Supplementary Concept]
- H2N-CH2-(CH2)9-CO-VKALDFRTPAKAKL-NH2 [MeSH Supplementary Concept]
- HIV type 1 lipopeptide vaccine [MeSH Supplementary Concept]
- HMR 1043 [MeSH Supplementary Concept]
- ICL1-9 pepducin [MeSH Supplementary Concept]
- INNA-051 [MeSH Supplementary Concept]
- JBT-3002 [MeSH Supplementary Concept]
- Lau-(Lys-betaNSpe)6-NH2 [MeSH Supplementary Concept]
- Lp44 lipopeptide [MeSH Supplementary Concept]
- MDN-0066 [MeSH Supplementary Concept]
- MX-2401 [MeSH Supplementary Concept]
- N,N'-dioleylglutamide [MeSH Supplementary Concept]
- N-(20-hydroxyeicosa-5,14-dienoyl)glycine [MeSH Supplementary Concept]
- N-acetylglutaminoyl-S-farnesylcysteine [MeSH Supplementary Concept]
- N-undecyl-10-enoylphenylalanine [MeSH Supplementary Concept]
- NAX 5055 [MeSH Supplementary Concept]
- NNC0195-0092 [MeSH Supplementary Concept]
- P2pal-18S pepducin [MeSH Supplementary Concept]
- PZ-128 peptide [MeSH Supplementary Concept]
- Pam(3)CSK(4) peptide [MeSH Supplementary Concept]
- Pam-Gly(-1)-Lys(0)-Arg(1)-Pro(2)-Pro(3)-Gly(4)-Phe(5)-Ser(6)-Pro(7)-Phe(8)-Arg(9)-OH [MeSH Supplementary Concept]
- Pam-Lys(0)-Arg(1)-Pro(2)-Pro(3)-Gly(4)-Phe(5)-Ser(6)-Pro(7)-Phe(8)-Arg(9)-OH [MeSH Supplementary Concept]
- Pam2CSK4 acetate and ODN M362 combination [MeSH Supplementary Concept]
- Pam2CSK4 lipopeptide [MeSH Supplementary Concept]
- PepFect14 peptide [MeSH Supplementary Concept]
- PepFect15 peptide [MeSH Supplementary Concept]
- PepFect6 peptide [MeSH Supplementary Concept]
- RGD-lipopeptide [MeSH Supplementary Concept]
- S-(2,3-bis(palmitoyloxy)propyl)cysteine [MeSH Supplementary Concept]
- S-(2,3-bispalmitoyloxypropyl)-cysteinyl-amido-monomethoxyl polyethylene glycol [MeSH Supplementary Concept]
- TAN 1511 A [MeSH Supplementary Concept]
- TAN 1511 B [MeSH Supplementary Concept]
- TAN 1511 C [MeSH Supplementary Concept]
- Theradigm-HBV [MeSH Supplementary Concept]
- TssJ protein, E coli [MeSH Supplementary Concept]
- V9T14 lipopeptide [MeSH Supplementary Concept]
- WF 11899A [MeSH Supplementary Concept]
- WF 11899B [MeSH Supplementary Concept]
- WF 11899C [MeSH Supplementary Concept]
- WH1fungin [MeSH Supplementary Concept]
- acremolides [MeSH Supplementary Concept]
- actinocarbasin [MeSH Supplementary Concept]
- acuminatum E [MeSH Supplementary Concept]
- acuminatum F [MeSH Supplementary Concept]
- aeruginosin-865 [MeSH Supplementary Concept]
- almiramide A [MeSH Supplementary Concept]
- almiramide B [MeSH Supplementary Concept]
- almiramide C [MeSH Supplementary Concept]
- almiramide D [MeSH Supplementary Concept]
- aminocandin [MeSH Supplementary Concept]
- amphomycin [MeSH Supplementary Concept]
- anikasin peptide, Pseudomonas fluorescens [MeSH Supplementary Concept]
- antillatoxin [MeSH Supplementary Concept]
- arthrofactin [MeSH Supplementary Concept]
- aselacin A [MeSH Supplementary Concept]
- aselacin B [MeSH Supplementary Concept]
- aselacin C [MeSH Supplementary Concept]
- aspartocin D [MeSH Supplementary Concept]
- aspartocin E [MeSH Supplementary Concept]
- bacillomycin DC [MeSH Supplementary Concept]
- bacillopeptin A [MeSH Supplementary Concept]
- bacillopeptin B [MeSH Supplementary Concept]
- bacillopeptin C [MeSH Supplementary Concept]
- bacilotetrin A [MeSH Supplementary Concept]
- bacilotetrin B [MeSH Supplementary Concept]
- balticidin A [MeSH Supplementary Concept]
- biseokeaniamide A [MeSH Supplementary Concept]
- biseokeaniamide B [MeSH Supplementary Concept]
- biseokeaniamide C [MeSH Supplementary Concept]
- bulevirtide [MeSH Supplementary Concept]
- burkholdine [MeSH Supplementary Concept]
- cavinafungin [MeSH Supplementary Concept]
- chromobactomycin, Chromobacterium [MeSH Supplementary Concept]
- ciliatamide A [MeSH Supplementary Concept]
- ciliatamide B [MeSH Supplementary Concept]
- ciliatamide C [MeSH Supplementary Concept]
- coryxin [MeSH Supplementary Concept]
- cryomycin [MeSH Supplementary Concept]
- cyclic lipopeptide, bacillus subtilis [MeSH Supplementary Concept]
- cyrmenin B1 [MeSH Supplementary Concept]
- cystargamide [MeSH Supplementary Concept]
- dideoxymycobactin [MeSH Supplementary Concept]
- dysoxylactam A [MeSH Supplementary Concept]
- enamidonin [MeSH Supplementary Concept]
- fellutamide B [MeSH Supplementary Concept]
- fengycin [MeSH Supplementary Concept]
- gageotetrin A [MeSH Supplementary Concept]
- gageotetrin B [MeSH Supplementary Concept]
- gageotetrin C [MeSH Supplementary Concept]
- gordonin [MeSH Supplementary Concept]
- gramibactin [MeSH Supplementary Concept]
- hassallidin A [MeSH Supplementary Concept]
- hassallidin C [MeSH Supplementary Concept]
- hassallidin D [MeSH Supplementary Concept]
- hoiamide C [MeSH Supplementary Concept]
- humimycin A [MeSH Supplementary Concept]
- humimycin B [MeSH Supplementary Concept]
- icosalide A1 [MeSH Supplementary Concept]
- icosalide A2 [MeSH Supplementary Concept]
- icosalide B [MeSH Supplementary Concept]
- ieodoglucomide C [MeSH Supplementary Concept]
- jahanyne [MeSH Supplementary Concept]
- jamaicamide A [MeSH Supplementary Concept]
- jamaicamide B [MeSH Supplementary Concept]
- jamaicamide C [MeSH Supplementary Concept]
- kozupeptin A [MeSH Supplementary Concept]
- kurahyne B [MeSH Supplementary Concept]
- laspartomycin C [MeSH Supplementary Concept]
- lipodiscamide A [MeSH Supplementary Concept]
- lipodiscamide B [MeSH Supplementary Concept]
- lipodiscamide C [MeSH Supplementary Concept]
- lipopeptide 84-201 [MeSH Supplementary Concept]
- lipopeptide 86-450 [MeSH Supplementary Concept]
- lipopeptide detergent 12 [MeSH Supplementary Concept]
- macrophage stimulatory lipopeptide 2 [MeSH Supplementary Concept]
- majusculamide D [MeSH Supplementary Concept]
- malacidins [MeSH Supplementary Concept]
- malleipeptin A [MeSH Supplementary Concept]
- malleipeptin B [MeSH Supplementary Concept]
- malyngamide 2 [MeSH Supplementary Concept]
- malyngamide 3 [MeSH Supplementary Concept]
- maribasin A [MeSH Supplementary Concept]
- maribasin B [MeSH Supplementary Concept]
- mebamamide A [MeSH Supplementary Concept]
- mebamamide B [MeSH Supplementary Concept]
- miramides [MeSH Supplementary Concept]
- muscotoxin A [MeSH Supplementary Concept]
- myrcludex-B [MeSH Supplementary Concept]
- myristoyl-cysteinyl-alanyl-valyl-alanyl-tyrosyl-(3-methyl)histidine methyl ester [MeSH Supplementary Concept]
- myristoyl-lysyl-leucyl-seryl-seryl-isoleucyl-glutamyl-seryl-aspartyl-valine [MeSH Supplementary Concept]
- octapeptin C4 [MeSH Supplementary Concept]
- octapeptin antibiotics [MeSH Supplementary Concept]
- octyl-tridecaptin A1 [MeSH Supplementary Concept]
- orfamide A [MeSH Supplementary Concept]
- paenibacterin [MeSH Supplementary Concept]
- palmitoyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide [MeSH Supplementary Concept]
- palmitoyl-lysyl-glycyl-lysinamide [MeSH Supplementary Concept]
- parguerene [MeSH Supplementary Concept]
- peptidolipin B [MeSH Supplementary Concept]
- peptidolipin E [MeSH Supplementary Concept]
- peptidolipin NA [MeSH Supplementary Concept]
- phaeofungin [MeSH Supplementary Concept]
- phomafungin [MeSH Supplementary Concept]
- precarriebowmide [MeSH Supplementary Concept]
- puwainaphycin F [MeSH Supplementary Concept]
- puwainaphycin G [MeSH Supplementary Concept]
- rakicidins [MeSH Supplementary Concept]
- relacidine B [MeSH Supplementary Concept]
- serine dipeptide lipid 654 [MeSH Supplementary Concept]
- spiroidesin [MeSH Supplementary Concept]
- surfactin A [MeSH Supplementary Concept]
- surfactin peptide [MeSH Supplementary Concept]
- surfactin, Ile(7)- [MeSH Supplementary Concept]
- surfactin, Leu(7)- [MeSH Supplementary Concept]
- surfactin-C15 [MeSH Supplementary Concept]
- taiwachelin [MeSH Supplementary Concept]
- tauramamide [MeSH Supplementary Concept]
- thanamycin [MeSH Supplementary Concept]
- thioamycolamide A [MeSH Supplementary Concept]
- trichoderin A [MeSH Supplementary Concept]
- trichoderin A1 [MeSH Supplementary Concept]
- trichoderin B [MeSH Supplementary Concept]
- trichogin A IV [MeSH Supplementary Concept]
- trichogin GA IV [MeSH Supplementary Concept]
- trichormamide A [MeSH Supplementary Concept]
- trichormamide B [MeSH Supplementary Concept]
- trichormamide C [MeSH Supplementary Concept]
- trichormamide D [MeSH Supplementary Concept]
- tripropeptin C [MeSH Supplementary Concept]
- tsushimycin [MeSH Supplementary Concept]
- variochelin A [MeSH Supplementary Concept]
- white-line-inducing principle, Lasiosphaera fenzlii [MeSH Supplementary Concept]
- zeta-inhibitory peptide [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients